-
Je něco špatně v tomto záznamu ?
Evaluation of platelet concentrates prepared from whole blood donations with collection times between 12 and 15 min: The BEST Collaborative study
D. de Korte, IJ. Bontekoe, Á. Fitzpatrick, D. Marks, B. Wood, U. Gravemann, M. Bohoněk, JM. Kutner, Biomedical Excellence for Safer Transfusion Collaborative
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články
PubMed
35023205
DOI
10.1111/vox.13245
Knihovny.cz E-zdroje
- MeSH
- dárci krve * MeSH
- konzervace krve MeSH
- lidé MeSH
- plazma bohatá na destičky * MeSH
- trombocyty MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
BACKGROUND AND OBJECTIVES: In many countries, whole blood (WB) donations with collection times between 12 and 15 min are not allowed to be used for platelet concentrates (PC). Since the development of guidelines, many process-related changes have been introduced. We aimed to determine the effect of WB with long collection times on PC quality. MATERIALS AND METHODS: Five participating centres tested buffy coat (BC)-derived PC in platelet additive solution type E prepared from only WB collections lasting <12 min (control) versus similar PC including one BC from a collection lasting >12 min (study group, n = 8). One centre produced platelet-rich plasma (PRP)-derived PC from single donations (<10 or >12 min). All PC were stored at 22 ± 2°C and sampled on Days 1, 6 and 8 post-collection for in vitro quality determination. RESULTS: Average collection time was significantly longer in the study group compared to controls (8.9 ± 2.6 vs. 7.3 ± 1.3 min, p < 0.001). There were no differences in volume, platelet concentration, basal CD62P expression, soluble-CD62P and CCL5 levels, or nucleotide content between the groups. Stimulation with TRAP-6 resulted in comparable levels of cell surface CD62P. On Day 8, all PC fulfilled requirements for pH. The findings from single PRP-derived PC centre were similar. CONCLUSION: PC with one BC and single PRP derived from collections lasting >12 min had equivalent in vitro quality to controls during storage. This study provides evidence that 12-15 min donations should not be excluded for PC preparation and justifies to readdress the guidelines to <15 min instead of <12 min of collection in line with current practice in some countries.
Blood Bank Product and Process Development Sanquin Blood Supply Amsterdam The Netherlands
German Red Cross Blood Service NSTOB Springe Germany
Hospital Israelita Albert Einstein São Paulo Brazil
Irish Blood Transfusion Service Dublin Ireland
Research and Development Australian Red Cross Blood Lifeblood Sydney New South Wales Australia
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018677
- 003
- CZ-PrNML
- 005
- 20220804134948.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1111/vox.13245 $2 doi
- 035 __
- $a (PubMed)35023205
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a de Korte, Dirk $u Blood Bank, Product and Process Development, Sanquin Blood Supply, Amsterdam, The Netherlands $1 https://orcid.org/0000000197727377
- 245 10
- $a Evaluation of platelet concentrates prepared from whole blood donations with collection times between 12 and 15 min: The BEST Collaborative study / $c D. de Korte, IJ. Bontekoe, Á. Fitzpatrick, D. Marks, B. Wood, U. Gravemann, M. Bohoněk, JM. Kutner, Biomedical Excellence for Safer Transfusion Collaborative
- 520 9_
- $a BACKGROUND AND OBJECTIVES: In many countries, whole blood (WB) donations with collection times between 12 and 15 min are not allowed to be used for platelet concentrates (PC). Since the development of guidelines, many process-related changes have been introduced. We aimed to determine the effect of WB with long collection times on PC quality. MATERIALS AND METHODS: Five participating centres tested buffy coat (BC)-derived PC in platelet additive solution type E prepared from only WB collections lasting <12 min (control) versus similar PC including one BC from a collection lasting >12 min (study group, n = 8). One centre produced platelet-rich plasma (PRP)-derived PC from single donations (<10 or >12 min). All PC were stored at 22 ± 2°C and sampled on Days 1, 6 and 8 post-collection for in vitro quality determination. RESULTS: Average collection time was significantly longer in the study group compared to controls (8.9 ± 2.6 vs. 7.3 ± 1.3 min, p < 0.001). There were no differences in volume, platelet concentration, basal CD62P expression, soluble-CD62P and CCL5 levels, or nucleotide content between the groups. Stimulation with TRAP-6 resulted in comparable levels of cell surface CD62P. On Day 8, all PC fulfilled requirements for pH. The findings from single PRP-derived PC centre were similar. CONCLUSION: PC with one BC and single PRP derived from collections lasting >12 min had equivalent in vitro quality to controls during storage. This study provides evidence that 12-15 min donations should not be excluded for PC preparation and justifies to readdress the guidelines to <15 min instead of <12 min of collection in line with current practice in some countries.
- 650 12
- $a dárci krve $7 D001782
- 650 _2
- $a trombocyty $7 D001792
- 650 _2
- $a konzervace krve $7 D001793
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a plazma bohatá na destičky $7 D053657
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Bontekoe, Ido J $u Blood Bank, Product and Process Development, Sanquin Blood Supply, Amsterdam, The Netherlands $1 https://orcid.org/0000000191037148
- 700 1_
- $a Fitzpatrick, Áine $u Irish Blood Transfusion Service, Dublin, Ireland
- 700 1_
- $a Marks, Denese $u Research and Development, Australian Red Cross Blood Lifeblood, Sydney, New South Wales, Australia $1 https://orcid.org/0000000236746934
- 700 1_
- $a Wood, Ben $u Research and Development, Australian Red Cross Blood Lifeblood, Sydney, New South Wales, Australia
- 700 1_
- $a Gravemann, Ute $u German Red Cross Blood Service NSTOB, Springe, Germany
- 700 1_
- $a Bohoněk, Miloš $u Haematology, Biochemistry and Blood Transfusion, Military University Hospital Prague, Prague, Czech Republic
- 700 1_
- $a Kutner, Jose M $u Hospital Israelita Albert Einstein, São Paulo, Brazil $1 https://orcid.org/0000000337846731
- 710 2_
- $a Biomedical Excellence for Safer Transfusion Collaborative
- 773 0_
- $w MED00010756 $t Vox sanguinis $x 1423-0410 $g Roč. 117, č. 5 (2022), s. 671-677
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35023205 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134941 $b ABA008
- 999 __
- $a ok $b bmc $g 1822344 $s 1169920
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 117 $c 5 $d 671-677 $e 20220112 $i 1423-0410 $m Vox sanguinis $n Vox Sang $x MED00010756
- LZP __
- $a Pubmed-20220720